PSY28 Cost-Effectiveness Analysis of Celecoxib in the Treatment of Chronic Pain in Patients With Osteoarthritis or Rheumatoid Arthritis Versus the Use of Etoricoxib or Lumiracoxib in Mexico
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.562
https://www.valueinhealthjournal.com/article/S1098-3015(12)00627-4/fulltext
Title :
PSY28 Cost-Effectiveness Analysis of Celecoxib in the Treatment of Chronic Pain in Patients With Osteoarthritis or Rheumatoid Arthritis Versus the Use of Etoricoxib or Lumiracoxib in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00627-4&doi=10.1016/j.jval.2012.03.562
First page :
A103
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
29